| ∆9-THC | Δ9-tetrahydrocannabinol |
| 2 AG | 2-arachidonoylglycerol |
| AC | anterior commissure |
| AgRP | agouti-related peptide |
| AgRP1 | agouti-related peptide 1 |
| AM251 | (N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide) |
| CB1R | cannabinoid receptor type 1 |
| CB2R | cannabinoid receptor type 2 |
| CBD | cannabidiol |
| DAGL | diacylglycerol lipase |
| DMSO | dimethyl sulfoxide |
| dpf | days post fertilization |
| eCB | endocannabinoid |
| GnRH | gonadotropin-releasing hormone |
| GTPase | guanosine triphosphatase |
| Hox | homeobox gene |
| hpf | hours post fertilization |
| JNK1 | c-Jun N-terminal kinase 1 |
| MAGL | monoacylglycerol lipase |
| MO | morpholino oligonucleotide |
| Negr1 | neuronal growth regulator 1 |
| POA | pre-optic area |
| POC | post-optic commissure |
| Rimonabant | SR141716, (N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)4-methyl-1H-pyrazole-3-carboxamide hydrochloride) |
| Sez6 | Seizure protein 6 |
| Stmn2/SCG10 | Stathmin2/Superior Cervical Ganglion-10 Protein |
| VTC | ventral tegmental commissure |
| WIN55 | WIN 55,212-2; (R)-( + )-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate |